EMAS position statement: Managing the menopause in women with a past history of endometriosis

Maturitas
Mette H MoenEuropean Menopause and Andropause Society

Abstract

Endometriosis is a common disease in women of reproductive age. The symptoms usually disappear after a natural or a surgical menopause. Estrogen-based hormone therapy is required in women with premature or early menopause until the average age of the natural menopause and should be considered in older women with severe climacteric symptoms. However use of hormone therapy raises concerns about disease recurrence with pain symptoms, need for surgery and possibly malignant transformation of residual endometriosis. To formulate a position statement on the management of the menopause in women with a past history of endometriosis. Literature review and consensus of expert opinion. The data regarding hormone therapy regimens are limited. However it may be safer to give either continuous combined estrogen-progestogen therapies or tibolone in both hysterectomised and nonhysterectomised women as the risk of recurrence may be reduced. The risk of recurrence with hormone therapy is probably increased in women with residual disease after surgery. Management of potential recurrence is best monitored by responding to recurrence of symptoms. Women not wanting estrogen or those who are advised against should be offered alternative pharmacologic...Continue Reading

References

Dec 1, 1980·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R PunnonenV Nikkanen
Jul 25, 2000·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·W G McCluggageD D Boyle
Dec 16, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·D W SturdeeA J Bragg
Jun 13, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T BeseM Arvas
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators
Nov 16, 2004·Lancet·Linda C Giudice, Lee C Kao
Apr 2, 2005·Obstetrics and Gynecology·Susan R JohnsonDeborah Grady
Jun 28, 2005·Human Reproduction·Stephen KennedyUNKNOWN ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group
Sep 27, 2006·Climacteric : the Journal of the International Menopause Society·N F Soliman, T C Hillard
Dec 29, 2006·The Journal of Clinical Endocrinology and Metabolism·David F ArcherFrans A Helmond
Apr 24, 2007·Menopause International·Joan PitkinJennifer Williamson
Apr 25, 2007·Climacteric : the Journal of the International Menopause Society·N PanayE Lang
Sep 14, 2007·Acta Obstetricia Et Gynecologica Scandinavica·Dorthe OxholmPernille Ravn
Aug 16, 2008·The New England Journal of Medicine·Steven R CummingsUNKNOWN LIFT Trial Investigators
Mar 3, 2009·Maturitas·Chrisandra L Shufelt, Glenn D Braunstein
Apr 7, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Veronica Chi Ken WongWu Shun Felix Wong
Jun 16, 2009·Molecular and Cellular Endocrinology·Tea Lanisnik Rizner
Jun 16, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Sudhindra Mohan Bhattacharya
Jun 30, 2009·Journal of Emergencies, Trauma, and Shock·Hanan M F Al Kadri
Jul 2, 2009·Acta Obstetricia Et Gynecologica Scandinavica·Bente FagervoldMette Haase Moen
Sep 8, 2009·Maturitas·Lynne T ShusterWalter A Rocca
Nov 12, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Omar SheblGernot Tews

❮ Previous
Next ❯

Citations

Feb 25, 2014·Maturitas·Margaret Rees
Aug 24, 2011·Obstetrics and Gynecology·Tommaso Falcone, Dan I Lebovic
May 12, 2015·Climacteric : the Journal of the International Menopause Society·S RozenbergM Fastrez
Sep 8, 2015·Women's Health·Umit Inceboz
May 23, 2012·Maturitas·Charlotte L Bendon, Christian M Becker
May 25, 2011·Maturitas·Toshiyuki YasuiShosuke Suzuki
Mar 19, 2013·American Journal of Obstetrics and Gynecology·Ivo BrosensGiuseppe Benagiano
Jun 17, 2016·Current Opinion in Obstetrics & Gynecology·Shahryar K KavoussiSawsan As-Sanie
Sep 14, 2016·Maturitas·Petra StuteMargaret Rees
Mar 27, 2013·Human Reproduction·Neil P JohnsonUNKNOWN World Endometriosis Society Montpellier Consortium
Apr 4, 2018·Climacteric : the Journal of the International Menopause Society·D A Tan, M J G Almaria
Jan 11, 2019·Climacteric : the Journal of the International Menopause Society·L AlioE Zupi
Mar 27, 2019·Hormone Molecular Biology and Clinical Investigation·Lydia Marie-ScemamaJean-Marc Ayoubi
Jul 6, 2019·Current Opinion in Obstetrics & Gynecology·Camille LadanyiShanti Mohling
Mar 4, 2020·Diagnostics·Cristina SecosanLaurentiu Pirtea
Oct 1, 2020·Post Reproductive Health·Rosamund Malhas, Lynne Robinson
May 13, 2017·Human Reproduction Update·L C GemmellC M Becker
Jul 27, 2018·Clinical Obstetrics and Gynecology·Kristin VAN Heertum, James Liu
Mar 16, 2019·Diseases·Michail MatalliotakisGeorge N Goulielmos
Feb 26, 2019·Gynecologic Oncology Reports·Katrin E EurichRenata R Urban

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Louise A BrintonLene Mellemkjaer
The New England Journal of Medicine
R J ChetkowskiH L Judd
© 2021 Meta ULC. All rights reserved